GSK plc
A Platform Modalities Leader at GSK provides enterprise-level scientific leadership for the modernization and evolution of analytical chemistry platforms. The role involves strategic expansion of capabilities to support complex therapeutic modalities, including antibody drug conjugates and oligonucleotides, through high-throughput and automated workflows. Success requires leading from the laboratory, influencing cross-functional teams, and shaping future platform strategies while maintaining regulatory compliance.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
GSK plc didn’t post a salary, so this is our estimate from similar listings.
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
Process Development Senior Scientist - Synthetic Peptides, Oligonucleotides, ADCs
Amgen
Scientist, Chemistry
MSD
Senior Scientist (Analytical, Bioscience Category)
AstraZeneca
Senior Scientist - Analytical Chemistry, Purification
Satomic
Director - Oligonucleotide Analytical Chemistry
Eli Lilly and Company
Organic and Conjugation Chemist
Amgen